(0.32%) 5 116.29 points
(0.31%) 38 357 points
(0.37%) 15 987 points
(-0.95%) $83.05
(5.36%) $2.03
(0.35%) $2 355.30
(0.49%) $27.67
(4.20%) $960.85
(-0.27%) $0.932
(-0.45%) $10.98
(-0.58%) $0.796
(1.63%) $93.37
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 6.23%
@ $37.43
発行日: 10 4月 2024 @ 04:35
リターン: -23.08%
前回のシグナル: 4月 10 - 02:42
前回のシグナル:
リターン: -0.27 %
Live Chart Being Loaded With Signals
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific...
Stats | |
---|---|
本日の出来高 | 550 627 |
平均出来高 | 1.43M |
時価総額 | 3.45B |
EPS | $0 ( 2024-02-15 ) |
次の収益日 | ( $-0.460 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.21 |
ATR14 | $0.0250 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Saxonov Serge | Buy | 88 854 | Class A Common Stock |
2024-03-21 | Hindson Benjamin J. | Buy | 71 083 | Class A Common Stock |
2024-03-21 | Mcanear Justin J. | Buy | 53 312 | Class A Common Stock |
2024-03-14 | Saxonov Serge | Sell | 1 086 | Class A Common Stock |
2024-03-04 | Saxonov Serge | Sell | 4 660 | Class A Common Stock |
INSIDER POWER |
---|
5.12 |
Last 100 transactions |
Buy: 4 660 285 | Sell: 4 260 557 |
ボリューム 相関
10X Genomics Inc 相関
10 最も正の相関 | |
---|---|
PRIM | 0.943 |
RYAAY | 0.935 |
FRSG | 0.933 |
NPAB | 0.932 |
SCAQ | 0.931 |
TWCB | 0.93 |
HOFT | 0.929 |
THCPU | 0.928 |
NBST | 0.928 |
OXAC | 0.926 |
10 最も負の相関 | |
---|---|
SVAC | -0.929 |
STAB | -0.929 |
RMRM | -0.922 |
AHPI | -0.914 |
APM | -0.902 |
AMGN | -0.899 |
LGMK | -0.894 |
GHVI | -0.892 |
ASPU | -0.892 |
TUEM | -0.891 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
10X Genomics Inc 相関 - 通貨/商品
10X Genomics Inc 財務諸表
Annual | 2023 |
収益: | $618.73M |
総利益: | $409.31M (66.15 %) |
EPS: | $-2.18 |
FY | 2023 |
収益: | $618.73M |
総利益: | $409.31M (66.15 %) |
EPS: | $-2.18 |
FY | 2022 |
収益: | $516.41M |
総利益: | $396.02M (76.69 %) |
EPS: | $-1.460 |
FY | 2021 |
収益: | $490.49M |
総利益: | $416.40M (84.89 %) |
EPS: | $-0.576 |
Financial Reports:
No articles found.
10X Genomics Inc
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。